LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
01 1LGM Pharma
02 1Alembic Pharmaceuticals Limited
03 1Anax Laboratories
04 1Beijing Mesochem Technology
05 1Beijing Sjar Technology Development
06 1Biotechnica DWC
07 1Cipla
08 1DEAFARMA
09 1Guangdong Raffles PharmaTech Co Ltd
10 1Guangzhou Tosun Pharmaceutical
11 1Hangzhou Longshine Bio-Tech
12 2Hetero Drugs
13 1Hunan Huateng Pharmaceutical Co ltd
14 2MSN Laboratories
15 1Mac-Chem Products (India) Pvt.Ltd
16 1Morepen Laboratories
17 1Sakar Healthcare
18 1Shenzhen HwaGen Pharmaceutical
19 1Shilpa Medicare
20 1Sichuan Qingmu Pharmaceutical
21 1Synthon Pharmaceuticals
22 1Tecoland Corporation
23 1Wisdom Pharmaceutical
24 1Zhejiang Jiuzhou Pharmaceutical
01 1Algeria
02 10China
03 11India
04 1Italy
05 1Netherlands
06 2U.S.A
01 6Active
02 20Blank
01 26Blank
01 26Blank
01 1WC-0041
02 1WC-0041A3
03 1WC-0082
04 1WC-0147A3
05 1WC-0349
06 21Blank
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-04-15
Pay. Date : 2015-10-29
DMF Number : 29918
Submission : 2015-10-10
Status : Active
Type : II
NDC Package Code : 65344-0033
Start Marketing Date : 2023-12-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-02-05
Pay. Date : 2015-12-23
DMF Number : 30104
Submission : 2015-12-24
Status : Active
Type : II
Date of Issue : 2021-06-11
Valid Till : 2022-07-02
Written Confirmation Number : WC-0147A3
Address of the Firm :
NDC Package Code : 82920-028
Start Marketing Date : 2022-08-15
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39323
Submission : 2023-12-27
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-06-27
Pay. Date : 2023-02-06
DMF Number : 37971
Submission : 2023-02-02
Status : Active
Type : II
Date of Issue : 2022-06-17
Valid Till : 2025-07-02
Written Confirmation Number : WC-0082
Address of the Firm :
We have 24 companies offering Axitinib
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?